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Establishing the precise evolutionary history of a gene
improves prediction of disease-causing missense mutations
Ogun Adebali, BSc1–3, Alexander O. Reznik, MD3,5, Daniel S. Ory, MD4 and Igor B. Zhulin, PhD1–3
Purpose: Predicting the phenotypic effects of mutations has become
an important application in clinical genetic diagnostics. Computational tools evaluate the behavior of the variant over evolutionary
time and assume that variations seen during the course of evolution
are probably benign in humans. However, current tools do not take
into account orthologous/paralogous relationships. Paralogs have
dramatically different roles in Mendelian diseases. For example,
whereas inactivating mutations in the NPC1 gene cause the neurodegenerative disorder Niemann-Pick C, inactivating mutations in its
paralog NPC1L1 are not disease-causing and, moreover, are implicated in protection from coronary heart disease.

whether an amino acid substitution affects protein function by reducing the organism’s fitness.

Methods: We identified major events in NPC1 evolution and revealed
and compared orthologs and paralogs of the human NPC1 gene
through phylogenetic and protein sequence analyses. We predicted
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INTRODUCTION

With the revolutionary developments in sequencing technologies,1 molecular testing is now widely used to support clinical
diagnosis and to identify unknown causes of genetic disorders.1–3 There are several approaches to evaluating the effect of
a variant: (i) evidence-based, (ii) frequency-based, (iii) functional (variants with obviously drastic consequences such as
nonsense and frameshift mutations), and (iv) predictive.4 The
first three approaches are successful in determining the effects
of variants but are limited when it comes to the variants of
unknown significance.1 For novel variants, which comprise the
majority of coding variation,5 in silico prediction is a quick way
is to estimate potential consequences. Computational tools,
such as PolyPhen6 and SIFT,7 are frequently used to evaluate genetic variations; however, they are not yet at the level
of desired performance in terms of sensitivity and specificity,
even for well-studied monogenic Mendelian diseases.4,8,9 These
tools take into account the following key parameters: sequence
conservation, structural constraints, and physiochemical properties of amino acids and known annotations, such as functionally important sites. Risk estimation is largely dependent
on the molecular conservation, which is inferred from comparative sequence analysis,10 and is based on the fact that most
disease-causing mutations cause a reduction of evolutionary
fitness; therefore, they are not selected for and are not observed

Results: Removing the paralogs and distant homologs improved
the overall performance of categorizing disease-causing and benign
amino acid substitutions.
Conclusion: The results show that a thorough evolutionary analysis
followed by identification of orthologs improves the accuracy in predicting disease-causing missense mutations. We anticipate that this
approach will be used as a reference in the interpretation of variants
in other genetic diseases as well.
Key Words: missense mutation prediction; Niemann-Pick; NPC1;
NPC1L1; orthologs and paralogs in disease

in homologs in other organisms.9 To identify homologous
sequences in other organisms, current tools use automated
sequence similarity searches followed by multiple sequence
alignment (MSA) and clustering. Consequently, sets of similar sequences that are used in the downstream analysis usually
include both orthologs and paralogs.6 This approach is based on
the argument that disease-causing substitutions far more often
affect protein structure than function,11 and although paralogous proteins may have a slightly different function, their structure is fully conserved.
However, the roles of paralogous genes in disease and health
are different. In most cases of Mendelian diseases, only one of
the paralogous genes is associated with the disease.12 In 87% of
the gene pairs, only one pair is associated with disease, and this
trend is observed in gene families with more than two members. Once a gene is duplicated, purifying selection pressure
on one or both of the copies is relaxed and they become more
prone to accumulating mutations. This divergence can lead to
sub-functionalization or neofunctionalization,13 often resulting
in different roles of paralogs in disease.
This pattern is observed in Niemann-Pick disease type C
(NP-C), which is a neurovisceral lysosomal lipid storage disease.14–16 NP-C is inherited in an autosomal recessive pattern and
is caused by mutations in either NPC1 or NPC2 genes.17 NPC1
and NPC2 proteins work in concert to transport cholesterol from
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the endosomal/lysosomal compartment.16,18 Homozygous loss
of function in either protein perturbs lipid homeostasis, which
results in pathogenicity. Ninety-five percent of affected individuals carry pathogenic mutations in the NPC1 gene,15 which
recently attracted attention because of its role in the entry of the
Ebola virus.19 By contrast, the NPC1 paralog, NPC1L1, is not
associated with the disease. On the contrary, inactivating mutations in NPC1L1 reduce the risk of coronary heart disease.20
NPC1 deletion in mice causes hearing loss,21 defects in retina,22
and deficiency in cerebellum development,23 whereas NPC1L1
deficiency protects ApoE-/- mice against atherosclerosis.24
Diagnosis of NP-C is challenging because of the heterogeneity in symptoms and clinical presentation.16 Until recently, the
diagnostic standard was filipin staining of unesterified cholesterol in fibroblasts obtained by skin biopsy.25,26 This test, however, is definitive in only approximately two-thirds of cases.
NP-C diagnostics has been significantly improved through
the discovery of cholesterol oxidation products (“oxysterols”)
that are elevated in the plasma of NP-C subjects.27 The plasma
oxysterol assay detects >97% of cases with 100% sensitivity.28
DNA sequencing offers another tool for NP-C diagnostics, but
in practice detects only ~85% of NP-C cases due to the large
number of private and noncoding sequence mutations.29 For
novel missense mutations, in silico tools are indispensable for
predicting potential NP-C. However, these tools use different
algorithms and data sets to build MSAs to assess the variant
effect, resulting in substantial inconsistencies.30 Researchers
usually rely on agreement between several tools, which has the
effect of increasing specificity while decreasing the sensitivity.31
Moreover, the tools that use conservation information do not
discriminate between orthologous and paralogous proteins6
and thus include NPC1 paralogs, such as NPC1L1, in their
analysis. Although including paralogs in risk-estimating data
sets is convenient (this eliminates computationally demanding
and often nontrivial steps to separate orthologs and paralogs),
such simplification confounds the function-specific signal.
NP-C disease caused by NPC1 mutations is an ideal case
study to understand the effects of paralogs in predicting
disease-causing mutations because of a dramatic consequence
of the duplication event that yielded NPC1L1. Moreover, many
experimentally validated disease-causing mutations as well as
alleles with high frequencies that are likely to be benign are
known for this gene (Supplementary Table S1 online).
In this study, we established the precise evolutionary history of
the NPC1 gene and identified evolutionary events that most likely
affected its function. We used this information to build a computational approach that showed improved accuracy in categorizing
damaging and benign single amino acid substitutions in NPC1.

MATERIALS AND METHODS
Databases, multiple sequence alignments, and
phylogenetic trees

Human NPC1 protein (NM_000271.4) was queried through
BLASTP32 against the human genome to reveal the related
sequences. Each hit was blasted individually against the RefSeq
1030
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database. For each job, the full sequences were compiled and
aligned using MAFFT default algorithm.33 Neighbor joining
tree was built with the phylip package.34 From the tree, the
NPC1 homologs clade was isolated. With the retrieved homologs, MAFFT version v7.154b E-INS-i algorithm was used to
realign the full-length sequences. The phylogenetic trees were
built using the maximum likelihood approach with PHYML
software version 2014092935 and applying the JTT substitution
model and the remaining parameters as default. The outgroups
that were not considered to be NPC1 homologs based on
RefSeq annotations and domain architectures were discarded
from the MSA, NPC1 homologs were realigned, and the final
phylogenetic tree was built.
Orthology assignment

Orthologs and paralogs were distinguished using the maximum likelihood phylogenetic tree. In case of major duplication events, a consistently more divergent duplicated clade was
categorized as paralogs that are less likely to retain the original
NPC1 function. The reference point for evolutionary distance
was determined as the full-length NPC1 node. In the cases in
which no divergence consistency between clades was observed
(e.g., not all species in clade A were more diverged than those
in clade B, or incomplete species set in both clades), the orthology assignment was deemed inconclusive. For the species-level
duplications, the sequence, which was significantly diverged
from the closest node of NPC1 orthologs, was categorized as
paralogous.
Scoring the effect of single amino acid variants

PubMed 1997–2014 database was searched to identify relevant
studies and case series. The initial search resulted in 312 articles. General review articles on NP-C disease, articles lacking
genetic testing, and experimental findings not connected with
clinical data were excluded. As a result, we identified 56 articles
referencing a total of 572 mutations in the NPC1 gene. After
excluding repetitive reports, insertion/deletion, frameshift and
nonsense mutations, and benign SNPs, the final list of the most
likely pathogenic nsSNVs comprised 166 variants that were
referred to as “damaging” variants in this study. To retrieve the
set of “benign” mutations, we used frequencies in human populations reported by Wassif et al.31 The variants found in humans
with higher frequency than the most common deleterious variant, I1063T, were categorized as benign. However, we removed
N222S, N961S, S1200G, and A521S from this list due to the
reports suggesting that they might be damaging.
In MSA, misaligned amino acids are masked based on the
queried position. First, residues adjacent to ambiguous amino
acids (represented by X) are masked. Second, if a sequence
has insertion or deletion in close proximity to the position of
interest, then that residue is masked. Selection of the representative isoform also depends on the queried position. Because
of the variations in splice sites, a single representative isoform
may not align well with the rest of the proteins for each position. Therefore, selection of the representative isoform based
Volume 18 | Number 10 | October 2016 | Genetics in medicine
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on the queried position yields better alignment quality. In the
algorithm, the “moderately variable” category was defined as
a position having more than five different substitutions in a
given set. Position was categorized as “hypervariable” if there
were more than nine different substitutions (see the source
code and related input files such as MSA and phylogenetic tree
at http://genomics.utk.edu/saver/source.rar).
Statistical analyses

The performance of the algorithm is described by the following
parameters: sensitivity; specificity; false discovery rate; accuracy;
F1 score; and Matthews correlation coefficient. In the equations
given here, TP, TN, FP, and FN refer to the number of true positives, true negatives, false positives, and false negatives, respectively.
Sensitivity =

TP
TP + FN

Specificity =

TN
TN + FP

Accuracy =

TP
P + TN
TP + TN + FP + FN

FDR = 1 −

TP
TP + FP

F1 = 1 −
MCC =

2TP
2TP + FP + FN
TP × TN − FP × FN
(TP + FP)(TP + FN)(TN + FN)(TN + FP)

Domain architecture prediction and risk map generation

To build domain architectures, we used the CDvist Web server
with HMMER3 against Pfam 27.0 and HHsearch against
Protein Data Bank options.36,37 Protein Data Bank HHsearch
probability cutoff was adjusted to 98%.
We implemented the SAVER algorithm in a PYTHON3 script
and ran it on all theoretical human NPC1 amino acid variants.
For each position, we counted the allowed (benign) amino
acids. The range was between 0 (no substitution allowed) and
19 (any substitution allowed). For secondary structure information, X-ray crystal structure (protein data bank ID: 3GKH)
was used for N-terminal domain and Psipred prediction was
used for the rest. The Protter Web application was used to generate the NPC1 membrane topology figure.38

RESULTS
Distinct clusters of NPC1 homologs suggest different
functions

NPC1 protein has 13 transmembrane (TM) regions with three
luminal domains. The crystal structure of the N-terminal
domain has been solved with bound cholesterol, indicating its
Genetics in medicine | Volume 18 | Number 10 | October 2016

Original Research Article
role in cholesterol binding and transport.39 The pentahelical
sterol-sensing domain, which resides between TM3 and TM8,
is required for cholesterol egress from the lysosome. There are
nine human genes that share similarity through their sterolsensing domains and are identifiable by BLASTP initiated with
NPC1: NPC1, NPC1-L1, PTCH1, PTCH2, PTCHD2, PTCHD3,
PTCHD4, SCAB SREBF, and DISP. These related proteins also
share the “Patched” domain, which has a role in cholesteroldependent processes. Domain architectures of these proteins
show significant differences, with only NPC1 and NPC1-L1 containing the N-terminal cholesterol-binding domain (Figure 1a).
A phylogenetic tree constructed from the MSA of all Patched
domain proteins shows distinct clades, where the NPC1NPC1L1 clade is clearly separated from the rest (Figure 1b).
These findings strongly suggest that other Patched-containing
sequences should not be taken into account when examining
function-specific characteristics of NPC1. In contrast, automated tools often include such functionally unrelated sequences
in their data sets (Supplementary Figure S1 online).
Major events in NPC1 evolution

NPC1 is found in four of the five eukaryotic supergroups—
unikonta, plants, chromalveolata, and excavates—and is missing from rhizaria. Phylogenetic analysis of NPC1 protein shows
that the NPC1 gene followed vertical evolution. Thus, it is likely
that NPC1 was present in the last eukaryotic common ancestor. Multiple gene duplication events are observed in taxonomic
ranks from superorder to species level; among 397 species with
NPC1, 195 (49%) have more than one copy (Supplementary
Figure S2 online).
In the common ancestor of gnathostomata (jawed vertebrates), the NPC1 gene was duplicated, giving rise to the
“NPC1-like” protein, which is present in most jawed vertebrates including humans (named NPC1L1). The NPC1L1 clade
is greatly diverged from the root when compared to the gnathostomatan NPC1 clade (Figure 2). NPC1 is present in each
organism that has NPC1-L1; however, the opposite is not true.
Moreover, the NPC1L1 clade has a longer average branch length
from its root, indicating a greater divergence (Supplementary
Figure S3 online). The NPC1L1 divergence and dispensability strongly suggest that its function is different from that of
NPC1, which is consistent with the observation that mutations in NPC1-L1 do not cause the disease. We observed a very
similar pattern of NPC1 duplication in neoptera (Figure 2 and
Supplementary Figure S3 online).
In fungi and amoebozoa, several duplications occurred, but
only at the species and genus level, suggesting there was no
major duplication event in these kingdoms.
In plants, there was NPC1 duplication in the common ancestor of flowering plants. More than one paralog is observed in
Pentapetalae. However, the distances of two clades from the
root are comparable (Figure 2). Furthermore, some organisms have only one version of the gene from either clade,
which suggests that one paralog is sufficient and neither copy is
indispensable. Internal diversity was comparable in two clades
1031
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Figure 1 Relationships between Patched domain–containing proteins. (a) The domain architectures of human Patched domain–containing proteins were
retrieved using the CDvist Web server. Boxes with a white background represent PFAM domains. Cholesterol-binding domains (in blue) were retrieved using a
PDB database profile. The cholesterol-binding domain was found exclusively in NPC1 and NPC1L1. (b) Some pairs such as PTCH1-PTCH2, NPC1-NPC1L1, and
PTCHD3-PTCHD4 have a relatively recent common ancestor, whereas the other proteins are related to each other more distantly, as they are represented as
single clades on the phylogenetic tree. According to the phylogenetic tree, the NPC1-NPC1L1 clade is clearly separated from other Patched domain–containing
sequences. PDB, protein data bank.

(Supplementary Figure S3 online). Therefore, the paralogs
may not have gained significantly different functions. Thus, the
Homo sapiens NPC1 (HsNPC1) orthology assignment cannot
be precisely performed in plants.
Unikonts (metazoa, fungi, and amoebozoa) and plants have
the full-length NPC1 protein with 13 TM regions, except for
Dictyostelium (Supplementary Figure S4 online). They all
accommodate a lumenal N-terminal domain that binds to
cholesterol. However, in Naegleria gruberi (excavate) and
in most chromalveolates, this domain is missing, resulting
in a shorter protein with 12 TM regions (Supplementary
Figure S4 online). We found that all organisms that lack the
NPC1 N-terminal domain have a separate protein (~300 amino
acids) encoded in their genomes, which is homologous (~30%
identity, ~50% similarity) to the N-terminal domain of the
full-length HsNPC1. Oomycetes have both “full” and “short”
versions of NPC1. In the phylogenetic tree, these two versions
are distinctly separated. Except for Nannochloropsis gaditana
(which has an atypical NPC1 with no sterol-sensing domain),
all organisms with the short version of the NPC1 protein
also have the separate cholesterol-binding protein. Moreover,
the separate cholesterol-binding protein is found exclusively
1032

in the organisms that have the short NPC1. The separate
cholesterol-binding protein is predicted to have a signal peptide
at the N-terminus and a TM region at the C-terminus. Thus,
concatenation of the separate cholesterol-binding protein and
the short version of NPC1 substantially resembles HsNPC1.
Exclusive coexistence of these two proteins suggests that they
interact and function similarly to the full version of NPC1. The
existence of both “full” and “short” versions in oomycetes and
the vertical evolutionary patterns suggest that both versions
could have been present in the last eukaryotic common ancestor, where either fusion or dissociation could have occurred;
then, only one version was kept in all organisms, except for
oomycetes, in which both were kept.
In addition to major duplication events, in each kingdom
there were also species and/or genus level duplications. In such
cases, one copy evolves slowly to keep the original function
and the extra copies, which are not prone to the same levels
of purifying selective pressure, diverge faster. We used the distance measurements from the common ancestor node in the
phylogenetic tree to determine the slowest evolving gene (the
clade with a shorter branch distance to the common ancestor), which in turn enabled us to find the functional orthologs.
Volume 18 | Number 10 | October 2016 | Genetics in medicine
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NPC1 gnathostomata
NPC1-Like 1 gnathostomata

Products of orthologous genes are very likely to perform the
same function. Therefore, distinguishing HsNPC1 orthologs from other homologous proteins is critical for identifying potentially pathogenic variants specifically affecting
HsNPC1 function. Detailed analysis of the phylogenetic tree
of all NPC1 homologs guided HsNPC1 orthology assignment. The clades retaining the original NPC1 function were
determined based on the agreement of three lines of evidence. First, we compared the distances of duplicated clades
to the full-length NPC1 root (Figure 2) to identify which
one is less diverged. Second, we compared the organism content of the clades. If a clade is a subset of another, then the
superset clade was considered the “original” one representing
HsNPC1 orthologs. Finally, diversity within the clades was
assessed; the less diverged clade is more likely to be ancestral
(Supplementary Figure S3 online). When all three criteria
agree, HsNPC1 orthologs can be identified with confidence.
However, in some cases, the sequence divergence information was inconclusive. In those cases, none of the clades was
a subset of another. Moreover, the diversity within the clades
was comparable. Consequently, these sequences were not
included in the set of HsNPC1 orthologs.

neoptera neoptera

Defining HsNPC1 functional orthologs

dikarya

Notably, NPC1 was lost in many parasites including whole
clades, such as microsporidia (fungi) and apicomplexa (chromalveolata). Except for N. gruberi, all species sequenced in the
Excavata supergroup are parasitic (Trypanosomatidae family,
Trichomonas vaginalis, and Giardia intestinalis) and contain no
NPC1 in their genomes.

Set 1
Set 2
Set 3
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Our master MSA included all homologs. We divided the master MSA into three sets grouped by the orthology relationships
(see Figure 2 for details). The phylogenetic clade containing
HsNPC1 after the most recent major evolutionary event, which
is the birth of NPC1L1 in gnathostomata, was considered the
core alignment. This alignment, referred to as “Set 1,” was
given the highest importance in the evaluation algorithm. Set 2
includes Set 1 and also other unambiguous HsNPC1 orthologs.
Finally, Set 3 contained all other HsNPC1 homologs, including
paralogs, except for the short versions of NPC1.
To predict the effect of missense mutations on HsNPC1 function, we propose an algorithm (SAVER: Single Amino Acid
Variant Evaluator) that provides binary output from the MSA
analysis of Sets 1 and 2 (Figure 3). In the scoring part, Set 1 is
given the highest weight because it contains HsNPC1 and its
orthologs that evolved after the most recent duplication and the
birth of many Mendelian diseases correlates with the time of
most recent duplications.12 However, using only Set 1, which is
limited in our case to bilaterian genomes, would not be sufficient
for collecting the entire ancestral information. For this reason,
Set 2 was used to compensate for the lack of evolutionary depth
in Set 1. Because Set 2 was carefully constructed from sequences
Genetics in medicine | Volume 18 | Number 10 | October 2016

viridiplantae

Evaluating missense mutations in HsNPC1: the scoring
algorithm

0.5

Figure 2 Maximum likelihood phylogenetic tree of NPC1 proteins
and described sets. The star is placed at the root of full-length NPC1. On
the left side, the black markers represent the closest NPC1 to the root for
each organism. Green markers (Sets 1 and 2) show the orthologs, whereas
red markers point to paralogs. Blue markers represent sequences that are
ambiguous in terms of orthology. The gray-shaded clade contains a short
version of NPC1. Set 1, which contains the HsNPC1 orthologs after the most
recent duplication, is a subset of Set 2.

that are likely to conserve the ancestral function of NPC1, the
amount of false signal it introduces is limited. Furthermore, the
possibility of false signals in Set 2 was addressed by lowering
its priority. Because sufficient evolutionary depth was reached
1033
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Figure 3 SAVER algorithm workflow.

with Set 2, specificity was not affected drastically by excluding
sequences only in Set 3.
Sequencing and aligning errors are key factors causing misinterpretation. Thus, working with the cleanest possible data
set, a nearly perfect alignment and well-constructed phylogenetic trees is critical for assessing the mutations. Ab initio
elimination of sequences that have misaligned regions is not an
optimum solution; therefore, we apply positional masking of
misaligned regions so that only well-aligned positions are taken
into account. Another challenge in eukaryotic sequence comparison is dealing with isoforms that can redundantly dominate
the signal and cause artificial conserved positions. We resolve
1034

this issue by choosing a representative isoform for each gene
that depends on the queried position.
For a single amino acid substitution from AA0 to AA1, scoring algorithms usually use the abundance of the AA1 in MSA.
However, instead of counting the number of sequences with
substitutions, we propose counting how many times a given
replacement has occurred independently so that a single evolutionary event would not be counted multiple times. Multiple
independent substitutions occurring in different clades suggest
that a position tolerates mutations, whereas a single substitution compensated by a suppressor mutation can be in a potentially “irreplaceable” position.

We scanned literature to retrieve known NPC1 variants. Only
single amino acid substitutions were taken into account. Only
biochemically validated NP-C–causing mutations were considered as “damaging” variants. Frequencies of HsNPC1 variants
from several exome sequencing data sets31 were used to define
the benign mutation data set. We selected the common variants
that have never been shown as pathogenic in any study and that
have frequency greater than 0.028%, which is the frequency of
the most commonly reported pathogenic variant, I1061T. Our
compiled control set contained 166 damaging and 21 benign
nsSNVs (Supplementary Table S1 online).
We tested our approach in comparison with automated tools
PolyPhen-2, SIFT, and PROVEAN.6,7,40 The results indicate that
our approach outperforms other tools in terms of sensitivity
(~10% improvement), while causing a relatively low cost in
specificity, and (ii) in terms of the overall quality, as measured
by the Matthews correlation coefficient (Table 1). The drastic
improvement in sensitivity can be explained by the fact that our
method eliminates the false evolutionary signals introduced by
functionally diverged sequences that are included in the analysis by other tools (Supplementary Table S1 online).
We also applied our method to all theoretical amino acid substitutions in NPC1; 24282 (1278 positions in NPC1 sequence
X 19 amino acid substitutions) theoretical single amino acid
variants were evaluated in comparison with the automated
methods described above (Supplementary Table S1 online).
Ultimately, our method predicts 81% of the variants as damaging, whereas PolyPhen-2, PROVEAN, and SIFT predict 60, 70
and 66% as damaging, respectively. Because we suspected that
our approach overpredicts damaging variants, we adjusted the
cutoffs of other tools to fix the damaging rate at 81%. After the
adjustment, the performance of two methods (PolyPhen-2 and
PROVEAN) was improved; however, none of them reached the
quality of our approach, as measured by the Matthews correlation coefficient value. Comparison between receiver-operating
characteristics of the tools and our “sensitivity false-positive
rate” datum shows a clear distinction of our result from the
general trend of the others (Supplementary Figure S5 online).
An example of how inclusion of paralogous sequences might
negatively affect the prediction is shown in Figure 4. Known
Volume 18 | Number 10 | October 2016 | Genetics in medicine
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Table 1 Performance comparison of tools predicting the effect of NPC1 missense mutations
Damaging (166)

Benign (21)

Tool

TP

FN

TN

FP

Sensitivity

Specificity

False
discovery rate

Accuracy

F1

MCC

SAVER

157

9

14

7

0.95

0.67

0.04

0.91

0.95

0.59

PP2

139

27

15

6

0.84

0.71

0.04

0.82

0.89

0.42

PROVEAN

141

25

15

6

0.85

0.71

0.04

0.83

0.90

0.43

SIFT

135

31

18

3

0.81

0.86

0.02

0.82

0.89

0.48

PP2adj

159

7

12

9

0.96

0.57

0.05

0.91

0.95

0.55

PROVEANadj

153

13

12

9

0.92

0.57

0.06

0.88

0.93

0.46

SIFTadj

150

16

11

10

0.90

0.52

0.06

0.86

0.92

0.38

The cutoffs distinguishing between “damaging” and “benign” variants are changed in the methods that are subscripted with the “adj” abbreviation based on the output
of the SAVER computation. SAVER and other “adjusted” tools yield an 81% damaging rate in all theoretical amino acid substitutions on HsNPC1.
FN, false negative; FP, false positive; MCC, Matthews correlation coefficient; TN, true negative; TP, true positive.

Figure 4 An alignment window illustrating false effects of paralogs in predicting damaging mutations. Blue-shaded sequences are HsNPC1
orthologs and the rest are paralogs. For each tool, the red marker represents “predicted as damaging” and the green marker represents “predicted as benign.”
Residues highlighted in red are the potential causes of predicting pathogenic variants as benign.

pathogenic mutations, N968S, G986S, G993A, and M995R (see
Supplementary Table S1 online), are predicted as benign by all
three automated tools, probably because the same substitutions
are found in NPC1L1 paralogs that are included in their MSA
sets (Figure 4). We generated a risk map for NPC1-caused NP-C
disease, where the topology of the human NPC1 is shown with
the positions colored based on the number of allowed substitutions (Supplementary Figure S6 online). This risk map provides clues about the functionally critical regions of HsNPC1
(Supplementary Text S1 online), and the full list of potentially
damaging and benign substitutions in this protein is provided
as Supplementary Table S2 online. We have built a Web-based
application for querying single amino acid variants in NPC1,
which can serve as a reference for clinicians. It is freely available
at http://genomics.utk.edu/saver/npc1.html.
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DISCUSSION

In this work, we showed that it is possible to get closer to the
desired level of predicting the effects of missense mutations
by carefully analyzing the evolutionary history of a gene.
A clear improvement is accomplished by taking into consideration only function-specific orthologous protein sequences.
Remote homologs and paralogs that are likely to be functionally diverged should be removed from the analysis. In selecting
functional counterparts, specific criteria based on a thorough
phylogenetic analysis must be used.
The proposed approach depends greatly on manual work
(constructing high-quality data sets, alignments, trees, and
defining orthologs and paralogs) as well as reasoning, which
depends on the output of a particular computational step. Thus,
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at this time, this approach cannot be fully automated and will not
replace any of the available automated tools. However, revealing
common trends and problems in identifying functional orthologs and testing this approach on other well-defined monogenic
Mendelian diseases should lead to the development of the next
generation of predictive automated methods directly applicable
in clinical practice.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper
at http://www.nature.com/gim
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